Topiramate affords neuroprotection in diabetic neuropathy model via downregulating spinal GFAP/inflammatory burden and improving neurofilament production

References

• Agarwal NB, Agarwal NK, Mediratta PK, Sharma KK. 2011. Effect of lamotrigine, oxcarbazepine and topiramate on cognitive functions and oxidative stress in PTZ-kindled mice. Seizure. 20(3):257–262.
   PubMed Web of Science ®Google Scholar
• Alare K, Alare T, Odunitan T, Adetunji B, Owonikoko O. 2020. Neurological and molecular basis of diabetic neuropathy. J Diabet Res Rev Rep. SRC/JDRR-120, 3.
   Google Scholar
• Ali SA, Zaitone SA, Dessouki AA, Ali AA. 2019. Pregabalin affords retinal neuroprotection in diabetic rats: suppression of retinal glutamate, microglia cell expression and apoptotic cell death. Exp Eye Res. 184:78–90.
   PubMed Web of Science ®Google Scholar
• Alomar SY, B MB, Eldosoky M, Atef H, Mohamed AS, Elhawary R, El-Shafey M, Youssef AM, Elkazaz AY, Gabr AM, et al. 2021. Protective effect of metformin on rat diabetic retinopathy involves suppression of toll-like receptor 4/nuclear factor-k B expression and glutamate excitotoxicity. Int Immunopharmacol. 90:107193.
   PubMed Web of Science ®Google Scholar
• Alomar SY, Gheit R, Enan ET, El-Bayoumi KS, Shoaeir MZ, Elkazaz AY, Al Thagfan SS, Zaitone SA, El-Sayed RM. 2021. Novel mechanism for memantine in attenuating diabetic neuropathic pain in mice via downregulating the spinal HMGB1/TRL4/NF-kB inflammatory axis. Pharmaceuticals (Basel). 14(4):307.
   PubMedGoogle Scholar
• Alzahrani S, Ajwah SM, Alsharif SY, Said E, El-Sherbiny M, Zaitone SA, Al-Shabrawey M, Elsherbiny NM. 2020. Isoliquiritigenin downregulates miR-195 and attenuates oxidative stress and inflammation in STZ-induced retinal injury. Naunyn Schmiedebergs Arch Pharmacol. 393(12):2375–2385.
   PubMed Web of Science ®Google Scholar
• Baum P, Toyka KV, Blüher M, Kosacka J, Nowicki M. 2021. Inflammatory mechanisms in the pathophysiology of diabetic peripheral neuropathy (DN)—new aspects. Int J Mol Sci. 22(19):10835.
   PubMed Web of Science ®Google Scholar
• Cao L, DeLeo J. 2008. CNS‐infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection‐induced neuropathic pain. Eur J Immunol. 38(2):448–458.
   PubMed Web of Science ®Google Scholar
• Cárdenas-Rodríguez N, Coballase-Urrutia E, Huerta-Gertrudis B, García-Cruz M, Pedraza-Chaverri J, Coria-Jiménez R, Bandala C, Ruíz-García MJNS. 2013. Antioxidant activity of topiramate: an antiepileptic agent. Neurol Sci. 34(5):741–747.
   PubMed Web of Science ®Google Scholar
• Cárdenas-Rodríguez N, Coballase-Urrutia E, Rivera-Espinosa L, Romero-Toledo A, Sampieri A III, Ortega-Cuellar D, Montesinos-Correa H, Floriano-Sánchez E, Carmona-Aparicio L. 2013. Modulation of antioxidant enzymatic activities by certain antiepileptic drugs (valproic acid, oxcarbazepine, and topiramate): evidence in humans and experimental models. Oxid Med Cell Longev. 2013:598493.
   Google Scholar
• Carroll DG, Kline KM, Malnar KF. 2004. Role of topiramate for the treatment of painful diabetic peripheral neuropathy. Pharmacotherapy: J Hum Pharmacol Drug Ther. 24(9):1186–1193.
   Google Scholar
• Cevikbas F, Kempkes C, Buhl T, Mess C, Buddenkotte J, Steinhoff M. 2014. Frontiers in Neuroscience; Role of Interleukin-31 and Oncostatin M in Itch and Neuroimmune Communication. In: Carstens E, Akiyama T, editors. Itch: mechanisms and Treatment. Boca Raton (FL): CRC Press/Taylor & Francis© 2014 by Taylor & Francis Group, LLC.
   Google Scholar
• Chaplan SR, Bach FW, Pogrel J, Chung J, Yaksh T. 1994. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 53(1):55–63.
   PubMed Web of Science ®Google Scholar
• Coleman ES, Dennis JC, Braden TD, Judd RL, Posner P. 2010. Insulin treatment prevents diabetes-induced alterations in astrocyte glutamate uptake and GFAP content in rats at 4 and 8 weeks of diabetes duration. Brain Res. 1306:131–141.
   PubMed Web of Science ®Google Scholar
• Das Evcimen N, King GL. 2007. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res. 55(6):498–510.
   PubMed Web of Science ®Google Scholar
• Daverey A, Agrawal SK. 2016. Curcumin alleviates oxidative stress and mitochondrial dysfunction in astrocytes. Neurosci. 333:92–103.
   PubMed Web of Science ®Google Scholar
• Edwards JL, Vincent AM, Cheng HT, Feldman EL. 2008. Diabetic neuropathy: mechanisms to management. Pharmacol Ther. 120(1):1–34.
   PubMed Web of Science ®Google Scholar
• El-Sherbeeny NA, Ibrahiem AT, Ali HS, Farag NE, Toraih EA, Zaitone SA. 2020. Carbamazepine conquers spinal GAP43 deficiency and sciatic Nav1.5 upregulation in diabetic mice: novel mechanisms in alleviating allodynia and hyperalgesia. Arch Pharm Res. 43(7):724–734.
   PubMed Web of Science ®Google Scholar
• Elsherbiny NM, Ahmed E, Kader GA, Abdel-Mottaleb Y, ElSayed MH, Youssef AM, Zaitone SA. 2019. Inhibitory effect of valproate sodium on pain behavior in diabetic mice involves suppression of spinal histone deacetylase 1 and inflammatory mediators. Int Immunopharmacol. 70:16–27.
   PubMed Web of Science ®Google Scholar
• Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, Bril V, Russell JW, Viswanathan V. 2019. Diabetic neuropathy. Nat Rev Dis Primers. 5(1):41.
   PubMed Web of Science ®Google Scholar
• Fernyhough P, Schmidt RE. 2002. Neurofilaments in diabetic neuropathy. Int Rev Neurobiol. 50:115–144.
   PubMed Web of Science ®Google Scholar
• Giovannoni F, Quintana FJ. 2020. The role of astrocytes in CNS inflammation. Trends Immunol. 41(9):805–819.
   PubMed Web of Science ®Google Scholar
• Group T, Thienel U, Neto W, Schwabe S, Vijapurkar U. 2004. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica. 110(4):221–231.
   PubMed Web of Science ®Google Scholar
• Holland NR, Stocks A, Hauer P, Cornblath DR, Griffin JW, McArthur JC. 1997. Intraepidermal nerve fiber density in patients with painful sensory neuropathy. Neurology. 48(3):708–711.
   PubMed Web of Science ®Google Scholar
• Huang XT, Li C, Peng XP, Guo J, Yue SJ, Liu W, Zhao FY, Han JZ, Huang YH, Cheng QM. 2017. An excessive increase in glutamate contributes to glucose-toxicity in β-cells via activation of pancreatic NMDA receptors in rodent diabetes. Sci Rep. 7(1):1–14.
   PubMedGoogle Scholar
• Hung CC, Lin CH, Chang H, Wang CY, Lin SH, Hsu PC, Sun YY, Lin TN, Shie FS, Kao LS, et al. 2016. Astrocytic GAP43 induced by the TLR4/NF-κB/STAT3 axis attenuates astrogliosis-mediated microglial activation and neurotoxicity. J Neurosci. 36(6):2027–2043.
   PubMed Web of Science ®Google Scholar
• Inoue KJP. 2006. The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol Ther. 109(1-2):210–226.
   PubMed Web of Science ®Google Scholar
• Jensen TS, Karlsson P, Gylfadottir SS, Andersen ST, Bennett DL, Tankisi H, Finnerup NB, Terkelsen AJ, Khan K, Themistocleous AC. 2021. Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management. Brain. 144(6):1632–1645.
   PubMedGoogle Scholar
• Khodeer DM, Zaitone SA, Farag NE, Moustafa YM. 2016. Cardioprotective effect of pioglitazone in diabetic and non-diabetic rats subjected to acute myocardial infarction involves suppression of AGE-RAGE axis and inhibition of apoptosis. Can J Physiol Pharmacol. 94(5):463–476.
   PubMed Web of Science ®Google Scholar
• Kikumoto Y, Sugiyama H, Inoue T, Morinaga H, Takiue K, Kitagawa M, Fukuoka N, Saeki M, Maeshima Y, Wang DH, et al. 2010. Sensitization to alloxan-induced diabetes and pancreatic cell apoptosis in acatalasemic mice. Biochim Biophys Acta. 1802(2):240–246.
   PubMed Web of Science ®Google Scholar
• Kosacka J, Baum P, Estrela-Lopis I, Stockinger M, Klöting N, Blüher M, Classen J, Thiery J, Bechmann I, Toyka KJDuS. 2016. The role of nerve inflammation and exogenous iron load in experimental peripheral diabetic neuropathy (PDN). Metabolism. 11(03):LB15.
   Google Scholar
• Kosacka J, Nowicki M, Kloting N, Kern M, Stumvoll M, Bechmann I, Serke H, Bluher M. 2012. COMP-angiopoietin-1 recovers molecular biomarkers of neuropathy and improves vascularisation in sciatic nerve of ob/ob mice. PLoS One. 7(3):e32881.
   PubMed Web of Science ®Google Scholar
• Kosacka J, Woidt K, Toyka KV, Paeschke S, Kloting N, Bechmann I, Bluher M, Thiery J, Ossmann S, Baum P, et al. 2019. The role of dietary non-heme iron load and peripheral nerve inflammation in the development of peripheral neuropathy (PN) in obese non-diabetic leptin-deficient ob/ob mice. Neurol Res. 41(4):341–353.
   PubMed Web of Science ®Google Scholar
• Levy DM, Terenghi G, Gu XH, Abraham RR, Springall DR, Polak JM. 1992. Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: relationship to tests of neurological function. Diabetologia. 35(9):889–897.
   PubMed Web of Science ®Google Scholar
• Liang Y, Chen X, Osborne M, DeCarlo S, Jetton T, Demarest K. 2005. Topiramate ameliorates hyperglycaemia and improves glucose‐stimulated insulin release in ZDF rats and db/db mice. Diabetes Obes Metab. 7(4):360–369.
   PubMed Web of Science ®Google Scholar
• Lopes LS, Pereira SS, Silva LL, Figueiredo KA, Moura BA, Almeida FR, Sousa FC. 2009. Antinociceptive effect of topiramate in models of acute pain and diabetic neuropathy in rodents. Life Sci. 84(3-4):105–110.
   PubMed Web of Science ®Google Scholar
• Louwsma J, Brunger AF, Bijzet J, Kroesen BJ, Roeloffzen WWH, Bischof A, Kuhle J, Drost G, Lange F, Kuks JBM, et al. 2021. Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis. Amyloid. 28(1):50–55.
   PubMed Web of Science ®Google Scholar
• McCall AL. 1992. The impact of diabetes on the CNS. Diabetes. 41(5):557–570.
   PubMed Web of Science ®Google Scholar
• Mohammad HMF, Sami MM, Makary S, Toraih EA, Mohamed AO, El-Ghaiesh SH. 2019. Neuroprotective effect of levetiracetam in mouse diabetic retinopathy: effect on glucose transporter-1 and GAP43 expression. Life Sci. 232:116588.
   PubMed Web of Science ®Google Scholar
• Moisset X, Bouhassira D. 2007. Brain imaging of neuropathic pain. Neuroimage. 37: S80–S88.
   PubMed Web of Science ®Google Scholar
• Nazarbaghi S, Amiri-Nikpour MR, Eghbal AF, Valizadeh R. 2017. Comparison of the effect of topiramate versus gabapentin on neuropathic pain in patients with polyneuropathy: a randomized clinical trial. Electron Physician. 9(10):5617–5622.
   PubMedGoogle Scholar
• Nukada H, McMorran PD, Baba M, Ogasawara S, Yagihashi S. 2011. Increased susceptibility to ischemia and macrophage activation in STZ-diabetic rat nerve. Brain Res. 1373:172–182.
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95(2):351–358.
   PubMed Web of Science ®Google Scholar
• Paeschke S, Baum P, Toyka KV, Bluher M, Koj S, Kloting N, Bechmann I, Thiery J, Kosacka J, Nowicki M. 2019. The role of iron and nerve inflammation in diabetes mellitus type 2-induced peripheral neuropathy. Neuroscience. 406:496–509.
   PubMed Web of Science ®Google Scholar
• Qiao X, Zhang S, Zhao W, Ye H, Yang Y, Zhang Z, Miao Q, Hu R, Li Y, Lu B. 2015. Serum phosphorylated neurofilament-heavy chain, a potential biomarker, is associated with peripheral neuropathy in patients with type 2 diabetes. Medicine (Baltimore). 94(44):e1908.
   PubMed Web of Science ®Google Scholar
• Raskin P, Donofrio PD, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, Vinik AI, Group C-S, CAPSS-141 Study Group 2004. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology. 63(5):865–873.
   PubMed Web of Science ®Google Scholar
• Reda HM, Zaitone SA, Moustafa YM. 2016. Effect of levetiracetam versus gabapentin on peripheral neuropathy and sciatic degeneration in streptozotocin-diabetic mice: influence on spinal microglia and astrocytes. Eur J Pharmacol. 771:162–172.
   PubMed Web of Science ®Google Scholar
• Renno WM, Alkhalaf M, Afsari Z, Abd-El-Basset E, Mousa A. 2008. Consumption of green tea alters glial fibriliary acidic protein immunoreactivity in the spinal cord astrocytes of STZ-diabetic rats. Nutr Neurosci. 11(1):32–40.
   PubMed Web of Science ®Google Scholar
• Ripoll N, Hascoet M, Bourin M. 2006. The four-plates test: anxiolytic or analgesic paradigm? Prog Neuropsychopharmacol Biol Psychiatry. 30(5):873–880.
   PubMed Web of Science ®Google Scholar
• Saad ZA, Khodeer DM, Zaitone SA, Ahmed AA, Moustafa YM. 2020. Exenatide ameliorates experimental non-alcoholic fatty liver in rats via suppression of toll-like receptor 4/NFκB signaling: Comparison to metformin. Life Sci. 253:117725.
   PubMed Web of Science ®Google Scholar
• Said E, Zaitone SA, Eldosoky M, Elsherbiny NM. 2018. Nifuroxazide, a STAT3 inhibitor, mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats. Chem Biol Interact. 281:111–120.
   PubMed Web of Science ®Google Scholar
• Sharma A, Tate M, Mathew G, Vince JE, Ritchie RH, de Haan JB. 2018. Oxidative stress and NLRP3-inflammasome activity as significant drivers of diabetic cardiovascular complications: therapeutic implications. Front Physiol. 9:114.
   PubMed Web of Science ®Google Scholar
• Sun Q, Wang C, Yan B, Shi X, Shi Y, Qu L, Liang X. 2019. Jinmaitong ameliorates diabetic peripheral neuropathy through suppressing TXNIP/NLRP3 inflammasome activation in the streptozotocin-induced diabetic rat model. Diabetes Metab Syndr Obes. 12:2145–2155.
   PubMed Web of Science ®Google Scholar
• Tang HY, Jiang AJ, Ma JL, Wang FJ, Shen GM. 2019. Understanding the signaling pathways related to the mechanism and treatment of diabetic peripheral neuropathy. Endocrinology. 160(9):2119–2127.
   PubMed Web of Science ®Google Scholar
• Tawfik MK, Helmy SA, Badran DI, Zaitone SA. 2018. Neuroprotective effect of duloxetine in a mouse model of diabetic neuropathy: role of glia suppressing mechanisms. Life Sci. 205:113–124.
   PubMed Web of Science ®Google Scholar
• Wang YX, Bowersox SS, Pettus M, Gao D. 1999. Antinociceptive properties of fenfluramine, a serotonin reuptake inhibitor, in a rat model of neuropathy. J Pharmacol Exp Therap. 291(3):1008–1016.
   PubMed Web of Science ®Google Scholar
• Wiffen PJ, Derry S, Lunn MP, Moore RA. 2013. Topiramate for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2013(8):CD008314.
   PubMed Web of Science ®Google Scholar
• Wilding C, Bell K, Funke S, Beck S, Pfeiffer N, Grus FH. 2015. GFAP antibodies show protective effect on oxidatively stressed neuroretinal cells via interaction with ERP57. J Pharmacol Sci. 127(3):298–304.
   PubMed Web of Science ®Google Scholar
• Yalcin I, Choucair‐Jaafar N, Benbouzid M, Tessier LH, Muller A, Hein L, Freund‐Mercier MJ, Barrot M. 2009. β2‐adrenoceptors are critical for antidepressant treatment of neuropathic pain. Ann Neurol. 65(2):218–225.
   PubMed Web of Science ®Google Scholar
• Yang H, Sloan G, Ye Y, Wang S, Duan B, Tesfaye S, Gao L. 2019. New perspective in diabetic neuropathy: from the periphery to the brain, a call for early detection, and precision medicine. Front Endocrinol (Lausanne). 10:929.
   PubMed Web of Science ®Google Scholar
• Zaitone SA, Alshaman R, Alattar A, Elsherbiny NM, Abogresha NM, El-Kherbetawy MK, Elaskary AA, Hashish AA, Rashed LA, Ahmed E. 2020. Retinoprotective effect of donepezil in diabetic mice involves mitigation of excitotoxicity and activation of PI3K/mTOR/BCl2 pathway. Life Sci. 262:118467.
   PubMed Web of Science ®Google Scholar
• Zaitone SA, Essawy S. 2012. Addition of a low dose of rimonabant to orlistat therapy decreases weight gain and reduces adiposity in dietary obese rats. Clin Exp Pharmacol Physiol. 39(6):551–559.
   PubMed Web of Science ®Google Scholar